Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.06.02, US 58179 P
2009.04.08, US 420793
Elizabeth Tringham ET AL: "T-Type Calcium Channel Blockers That Attenuate Thalamic Burst Firing and Suppress Absence Seizures", , 15 February 2012 (2012-02-15), pages 1-13, XP055373087, Retrieved from the Internet: URL:http://stm.sciencemag.org/content/4/12 1/121ra19.full.pdf [retrieved on 2017-05-16] (B1)
LOPEZ-RODRIGUEZ M L ET AL: "Benzimidazole derivatives. Part I: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 7, 1 January 1999 (1999-01-01), pages 2271-2281, XP002253669, ISSN: 0968-0896, DOI: 10.1016/S0968-0896(99)00172-8 (B1)
MCCALMONT F W ET AL: "Design, synthesis, and biological evaluation of novel T-type calcium channel antiagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 14, no. 14, 1 January 2004 (2004-01-01), pages 3691-3695, XP002986396, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2004.05.011 (B1)
PABLO MIGUEL CASILLAS-ESPINOSA ET AL: "Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model", PLOS ONE, vol. 10, no. 8, 14 August 2015 (2015-08-14), page e0130012, XP055372894, DOI: 10.1371/journal.pone.0130012 (B1)
ZHI-QIANG YANG ET AL: "Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels", JOURNAL OF MEDICINAL CHEMI, AMERICAN CHEMICAL SOCIETY, vol. 51, no. 20, 23 October 2008 (2008-10-23), pages 6471-6477, XP008140561, ISSN: 0022-2623, DOI: 10.1021/JM800830N [retrieved on 2008-09-26] (B1)
WILLIAM D. SHIPE ET AL: "Design, Synthesis, and Evaluation of a Novel 4-Aminomethyl-4-fluoropiperidine as a T-Type Ca 2+ Channel Antagonist", JOURNAL OF MEDICINAL CHEMISTRY, vol. 51, no. 13, 1 July 2008 (2008-07-01), pages 3692-3695, XP055011949, ISSN: 0022-2623, DOI: 10.1021/jm800419w (B1)
WO-A1-2004/046110 (B1)
WO-A2-2007/002361 (B1)
WO-A2-2007/002884 (B1)
VICTOR N. UEBELE ET AL: "Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice", JOURNAL OF CLINICAL INVESTIGATION, vol. 119, no. 6, 1 June 2009 (2009-06-01), pages 1659-1667, XP055012233, ISSN: 0021-9738, DOI: 10.1172/JCI36954 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3189839)
|
Innkommende, AR385058487
Korrespondanse (Hovedbrev inn)
|
Utgående
EP defect letter
|
Innkommende, AR384712505
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 16. avg. år (EP) | 2024.06.27 | 6760 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 15. avg. år (EP) | 2023.06.28 | 4850 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2022.06.29 | 4500 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2021.06.29 | 4200 | COMPUTER PACKAGES INC. | Betalt og godkjent |
32012097 expand_more expand_less | 2020.09.11 | 5500 | OSLO PATENTKONTOR AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Forsinkelsesavgift patent | 2020.08.27 | 700 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2020.08.27 | 3850 | COMPUTER PACKAGES INC. | Betalt og godkjent |